Garvan Institute of Medical Research
Garvan Institute of Medical Research
Sydney, New South Wales, Australia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Preventing Cognitive Decline with Metformin | Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Inflammation, Insulin Resistance, Nerve Degeneration, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nervous system disorder, psychiatric disorder, vascular disorder | Active, not recruiting | Phase 3 | 2024-10-02 | NCT04511416 |